To view this email as a web page, click here.
Conference Coverage
 
 July 30, 2019
 
Catch up on sessions you may have missed from AAD’s Summer Meeting in New York this past weekend by visiting our conference coverage page.
 
BUSINESS
 
Practice model trends
The good news for the specialty is practice model options are aplenty and there’s something for every dermatologist. Betsy Wernli, M.D., discussed factors behind dermatologists opting out of solo practice and misperceptions around various practice models Saturday at the Summer meeting of the American Academy of Dermatology.
More
 
Today’s practice model options
Betsy Wernli, M.D., president, Forefront Dermatology, offers insights into pros and cons of various practice model options.
More
ADVERTISEMENT
 
DIET AND DISEASE
 
Diet matters in atopic dermatitis
image description here The narrative about food, diet and atopic dermatitis recently changed significantly after publication of the Learning Early About Peanut study, says Peter Lio, M.D. Diet matters, and he discusses in what ways.

Find out more
 
Diet-acne association becomes clearer
image description here There have been several shifts over time around beliefs in the association between diet and acne. Linda Stein Gold, M.D., discussed the recommendations of current guidelines at the summer meeting of the American Academy of Dermatology.

Find out more
 
CLINICAL CONSIDERATIONS
 
Powerful immunosuppressant agents predispose patients to fungal infections
image description here Patients on powerful immunocompromising agents might be predisposed to infections; however the potential association between biologic agents and increased risk isn’t necessarily universal, Whitney High, M.D., reported during the summer meeting of the American Academy of Dermatology.

Find out more
 
Dermatologist explains over-the-counter hair loss treatments
image description here Kimberly S. Salkey, M.D., shares answers to some of the most common questions she encounters from patients about OTC hair loss treatments.

Find out more
 
GEP testing promising in melanoma
image description here GEP testing could improve staging accuracy and help streamline disease management, but more research is needed to determine if a high-risk GEP classification is associated with improved response to newer systemic therapies.

Find out more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.